User:Mr. Ibrahem/Anidulafungin

Anidulafungin, sold under the brand name Eraxis and Ecalta among others, is an antifungal used to treat invasive candidiasis and esophageal candidiasis. It is given by injection into a vein.

Common side effects include diarrhea, nausea, and low potassium. Other side effects may include liver problems and anaphylaxis. Use in pregnancy may harm the baby. It is an echinocandin and works by interfering with the production of a component of the fungal cell wall known as (1→3)-β- D -glucan.

Anidulafungin was approved for medical use in the United States in 2006 and Europe in 2007. It is available as a generic medication. It is on the World Health Organization's List of Essential Medicines as an alternative to micafungin. In the United Kingdom 100 mg costs the NHS about £300 as of 2021. This amount in the United States is about 200 USD.